Showing results (471-480 of 1,372) with videos related to
Sort By:
Pageof 138
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 20, 2023
Statistical harmonization of everyday functioning and dementia-related behavioral measures across nine surveys and trialsDiefei Chen, Eric Jutkowitz, Alden L GrossAlzheimer'S & Dementia (Amsterdam, Netherlands)|May 21, 2020
Composite cognitive and functional measures for early stage Alzheimer's disease trialsLon S Schneider, Terry E GoldbergAlzheimer'S & Dementia (Amsterdam, Netherlands)|February 13, 2023
Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological reviewStuart G Nicholls, Ahmed A Al-Jaishi, Harrison Niznick, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 6, 2023
Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40Julie K Wisch, Brian A Gordon, Anna H Boerwinkle, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 23, 2023
Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi-site cohortChristina B Young, Elizabeth C Mormino, Kathleen L Poston, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2022
Subjective cognitive decline in Brazil: Prevalence and association with dementia modifiable risk factors in a population-based studyWyllians Vendramini Borelli, Eduardo R Zimmer, Andrei Bieger, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2025
Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteriaLeonardo E Ariello, Daniele de Paula Faria, Thais de S Andrade, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 24, 2025
Plasma lipid metabolites as biomarkers of early white matter degeneration in Alzheimer's diseaseAlireza Shaabanpoor Haghighi, Hamide Nasiri, Arman Ghayourvahdat, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 17, 2025
Clinical validation and machine learning optimization of MyCog: A self-administered cognitive screener for primary care settingsStephanie Ruth Young, Yusuke Shono, Katherina Hauner, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 12, 2026
Procrastination as a marker of cognitive decline: Evidence from longitudinal transitions in the older adult populationCormac Monaghan, Rafael de Andrade Moral, Michelle Kelly, et al.Pageof 138